| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2718733 | The American Journal of Medicine | 2013 | 9 Pages |
Abstract
Use of evidence-based acute myocardial infarction treatments remains less than ideal for certain high-risk populations. The close correlations among factors associated with underperformance highlights the potential for specifically targeting and tailoring quality improvement interventions.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Dharam J. MD, SM, Gregg C. MD, Christopher P. MD, Adrian F. MD, Eric D. MD, MPH, W. Frank MD, Warren K. MD, Wenqin PhD, Lee H. MD, Deepak L. MD, MPH,